: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

As of October 2023, Amedeo had
12,263 active subscribers

Anemia

Free Subscription

Articles published in Br J Haematol
Retrieve available abstracts of 378 articles:
HTML format

Single Articles

December 2023

PIZZO A, Porter JS, Carroll Y, Burcheri A, et al
Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.
Br J Haematol. 2023;203:712-721.
PubMed Abstract available

MISHKIN AD, Prince EJ, Leimbach EJ, Mapara MY, et al
Psychiatric comorbidities in adults with sickle cell disease: A narrative review.
Br J Haematol. 2023;203:747-759.
PubMed Abstract available

November 2023

GREEN NS, Rosano C, Bangirana P, Opoka R, et al
Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia.
Br J Haematol. 2023;203:460-467.
PubMed Abstract available

BANDINI P, Borras N, Fernandez Mellid E, Martin-Fernandez L, et al
First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
Br J Haematol. 2023;203:e102-e107.
PubMed

STEWART GW, Gibson JS, Rees DC
The cation-leaky hereditary stomatocytosis syndromes: A tale of six proteins.
Br J Haematol. 2023;203:509-522.
PubMed Abstract available

NOVAK W, Berner J, Svaton M, Jimenez-Heredia R, et al
Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.
Br J Haematol. 2023;203:678-683.
PubMed Abstract available

SCULLY M, Rayment R, Clark A, Westwood JP, et al
A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
Br J Haematol. 2023;203:546-563.
PubMed Abstract available

FERMO E, Zaninoni A, Vercellati C, Marcello AP, et al
When alpha spectrin null alleles meet low expression alpha spectrin polymorphisms.
Br J Haematol. 2023;203:684-687.
PubMed

October 2023

ALADJIDI N, Pincez T, Rieux-Laucat F, Nugent D, et al
Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
Br J Haematol. 2023;203:28-35.
PubMed Abstract available

RANQUE B, Diaw M, Dembele AK, Lapoumeroulie C, et al
Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub-Saharan Africa (the BIOCADRE study).
Br J Haematol. 2023;203:319-326.
PubMed Abstract available

ALSULTAN A, Abujoub R, Alsudairy R, Memon S, et al
Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
Br J Haematol. 2023;203:255-263.
PubMed Abstract available

HEBBEL RP, Milbauer L, Wei P
A novel promoter of endothelial dysfunction in African Americans: Relevance to sickle cell anaemia.
Br J Haematol. 2023;203:e71-e73.
PubMed

September 2023

ZHANG Y, Xie H, Liang G, Qin Y, et al
A novel gain-of-function PIP4K2A mutation elevates the expression of beta-globin and aggravates the severity of alpha-thalassemia.
Br J Haematol. 2023;202:1018-1023.
PubMed Abstract available

NANNELLI C, Bosman A, Cunningham J, Dugue PA, et al
Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification.
Br J Haematol. 2023;202:1024-1032.
PubMed Abstract available

DE ALCANTARA PEDRO PP, Castro CHM, Pinheiro MM, Goncalves LM, et al
Vertebral fractures and low lean mass in young men with sickle cell disease: Lack of association with bone mineral density and clinical characteristics.
Br J Haematol. 2023;202:e46-e49.
PubMed

HAN J, Saraf SL, Gordeuk VR
Vaccination in sickle cell disease: Immunocompromised or immunocompetent?
Br J Haematol. 2023;202:916-918.
PubMed Abstract available

ESPERTI S, Nader E, Boisson C, Carin R, et al
Mitochondria retention in mature RBCs from haemoglobin SC patients.
Br J Haematol. 2023;202:e36-e38.
PubMed

KNIGHT-MADDEN J, King L, Asnani M, Skyers N, et al
Needs assessment in adults and parents of children living with sickle cell disease in Jamaica.
Br J Haematol. 2023;202:e31-e35.
PubMed

NAKAHARA H, Cheedarla N, Verkerke HP, Cheedarla S, et al
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
Br J Haematol. 2023;202:937-941.
PubMed Abstract available

GUPTA A, Gooda R, Marouf R
Pseudo-Gaucher cells in a splenectomised Beta-Thalassemia patient.
Br J Haematol. 2023;202:911.
PubMed

ZOLLER H, Wagner S, Schaefer B
What is wrong in doing good?
Br J Haematol. 2023;202:1089-1090.
PubMed Abstract available

ASHER S, Shah R, Ings S, Horder J, et al
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
Br J Haematol. 2023;202:1224-1227.
PubMed

DASARI S, Tse W, Wang J
Real-world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors.
Br J Haematol. 2023;202:1205-1208.
PubMed Abstract available

CHU Z, Cushway T, Wong M, Lim KX, et al
Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-A 3-year experience from a single institution in Singapore.
Br J Haematol. 2023;202:1199-1204.
PubMed Abstract available

MANGANAS K, Delicou S, Xydaki A, Kourakli A, et al
Predisposing factors for advanced liver fibrosis in patients with sickle cell disease.
Br J Haematol. 2023;202:1192-1198.
PubMed Abstract available

JACOBS JW, Ding JJ, Tormey CA, Abels EA, et al
Where do they go? The clinical conundrum of warm autoantibodies and their inability to cause haemolytic disease of the foetus and newborn.
Br J Haematol. 2023;202:1213-1215.
PubMed

August 2023

ELSHERIF L, Kanthakumar P, Afolabi J, Stratton AF, et al
Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia.
Br J Haematol. 2023;202:669-673.
PubMed Abstract available

GIBSON JS, Stewart GW
A critical role for altered red cell cation permeability in pathogenesis of sickle cell disease and other haemolytic anaemias.
Br J Haematol. 2023;202:462-464.
PubMed Abstract available

NADER E, Conran N, Leonardo FC, Hatem A, et al
Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner.
Br J Haematol. 2023;202:657-668.
PubMed Abstract available

HAMANI S, Lioure B, Nicolae A, Lipsker D, et al
A Rare Cause of Refractory Anaemia hidden between Folds.
Br J Haematol. 2023;202:712.
PubMed

JOLY P, Nader E, Ketels F, Boisson C, et al
Effects of pyruvate kinase activators on red blood cell properties in sickle cell disease.
Br J Haematol. 2023;202:e27-e30.
PubMed

ZHANG X, Han J, Shah BN, Saraf SL, et al
Platelet count decline and high neutrophil count within the first day of admission for painful sickle cell vaso-occlusive episodes predict severe complications.
Br J Haematol. 2023;202:e20-e23.
PubMed

MARTIN OY, Margulies S, Speller-Brown B, Majumdar S, et al
The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron.
Br J Haematol. 2023;202:479-484.
PubMed Abstract available

July 2023

RAI MP, Lee EJ, Bussel JB
Maintenence rituximab following induction in autoimmune cytopenias.
Br J Haematol. 2023;202:153-158.
PubMed Abstract available

HAROUN E, Dutta D, Lim SH
Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease.
Br J Haematol. 2023;202:184-194.
PubMed Abstract available

FERRONE FA
More of the same? Voxelotor spawns a successor, but on what success does it build?
Br J Haematol. 2023;202:13-15.
PubMed

DUFU K, Alt C, Strutt S, Partridge J, et al
GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
Br J Haematol. 2023;202:173-183.
PubMed Abstract available

June 2023

SHETH S, Taher AT, Coates TD, Kattamis A, et al
Management of luspatercept therapy in patients with transfusion-dependent beta-thalassaemia.
Br J Haematol. 2023;201:824-831.
PubMed Abstract available

WU J, Wang J, Tang N, Wang X, et al
An atypical patient with bone marrow failure syndrome-2 without microcephaly and learning disability in a Chinese family.
Br J Haematol. 2023;201:e50-e53.
PubMed

LIN Y, Del Giudice ME, Kron A, Meirovich H, et al
A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia.
Br J Haematol. 2023;201:1000-1004.
PubMed

PENG Y, Liang L, Zhang H, Liu H, et al
Single-cell profiling of ineffective erythropoiesis in a mouse model of beta-thalassaemia intermedia.
Br J Haematol. 2023;201:982-994.
PubMed Abstract available

BAIN BJ, Daniel Y, Henthorn J, de la Salle B, et al
Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
Br J Haematol. 2023;201:1047-1065.
PubMed Abstract available

JACOBS JW, Stephens LD, Allen ES, Binns TC, et al
Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic review.
Br J Haematol. 2023;201:1025-1032.
PubMed Abstract available

GENDREAU S, Cecchini J, Perier F, Razazi K, et al
Effect of high-flow oxygen therapy on regional oxygen saturation during vaso-occlusive pain crisis: An observational study.
Br J Haematol. 2023;201:e58-e61.
PubMed

TAKASAKI K, Friedman DF, Uter S, Vege S, et al
Variant RHD alleles and Rh immunization in patients with sickle cell disease.
Br J Haematol. 2023;201:1220-1228.
PubMed Abstract available

LI J, Wang Y, Zhang Y, Zhang X, et al
Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysis.
Br J Haematol. 2023;201:1179-1191.
PubMed Abstract available

CHEMINET G, Brunetti A, Khimoud D, Ranque B, et al
Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission.
Br J Haematol. 2023;201:1229-1238.
PubMed Abstract available

JARISCH A, Salzmann-Manrique E, Soerensen J, Sach G, et al
Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
Br J Haematol. 2023;201:1159-1168.
PubMed Abstract available

May 2023

GAVILLET M, Rufer N, Grandoni F, Rizzi M, et al
Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
Br J Haematol. 2023;201:581-584.
PubMed

PICCIN A, Magzoub I, Hervig T
The 'scintilla' starting vaso-occlusion in sickle cell disease.
Br J Haematol. 2023;201:379-380.
PubMed

AN R, Man Y, Cheng K, Zhang T, et al
Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
Br J Haematol. 2023;201:552-563.
PubMed Abstract available

TOWERMAN AS, Guilliams KP, Guerriero R, Shinawi MS, et al
Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.
Br J Haematol. 2023;201:e30-e33.
PubMed

LUNATI-ROZIE A, Janin A, Faubert E, Nony S, et al
Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis.
Br J Haematol. 2023;201:e46-e49.
PubMed

TENNENBAUM J, Volle G, Pouchot J, Joseph L, et al
Increased risk of venous thromboembolism in splenectomized patients with sickle cell disease.
Br J Haematol. 2023;201:793-796.
PubMed

April 2023

SICA M, Barone F, Nannelli C, Ricci P, et al
The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.
Br J Haematol. 2023;201:e1-e4.
PubMed

KAPUR R
The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
Br J Haematol. 2023;201:13-14.
PubMed Abstract available

ROSSI M, Pirenne F, Le Roux E, Smaine D, et al
Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: A retrospective study in a French national reference centre.
Br J Haematol. 2023;201:125-132.
PubMed Abstract available

WANG YM, Loveless M, Miller E, Nelson AS, et al
Phenotypes of adults with Fanconi anaemia.
Br J Haematol. 2023;201:133-139.
PubMed Abstract available

RABELO IB, Chiba AK, Moritz E, D'Amora P, et al
Metabolomic profile in patients with primary warm autoimmune haemolytic anaemia.
Br J Haematol. 2023;201:140-149.
PubMed Abstract available

JACOB M, Kawadler JM, Murdoch R, Ahmed M, et al
Brain volume in Tanzanian children with sickle cell anaemia: A neuroimaging study.
Br J Haematol. 2023;201:114-124.
PubMed Abstract available

KOREN A
The continuing global challenges of treating patients with beta-thalassemia.
Br J Haematol. 2023;201:183-184.
PubMed Abstract available

JACOBS JW, Binns TC, Abels E, Tormey CA, et al
Autoimmune haemolytic anaemia secondary to babesiosis: A review of reported cases and description of a novel association with cold antibody-mediated haemolytic anaemia.
Br J Haematol. 2023;201:364-369.
PubMed

SUTRA DEL GALY A, Willems L, D'Aveni M, Pautas C, et al
Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
Br J Haematol. 2023;201:e16-e20.
PubMed

HOKLAND P, Daar S, Khair W, Sheth S, et al
Thalassaemia-A global view.
Br J Haematol. 2023;201:199-214.
PubMed Abstract available

DONZE C, Benoit A, Thuret I, Faust C, et al
beta-Thalassemia in childhood: Current state of health in a high-income country.
Br J Haematol. 2023;201:334-342.
PubMed Abstract available

EARLEY EJ, Kelly S, Fang F, Alencar CS, et al
Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
Br J Haematol. 2023;201:343-352.
PubMed Abstract available

JACOBS JW, Booth GS, Guarente J, Schlafer D, et al
Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
Br J Haematol. 2023;201:227-233.
PubMed Abstract available

March 2023

IBEMERE SO, Oyedeji CI, Preiss L, Van Althuis LE, et al
Characterising the prevalence of overweight and obese status among adults with sickle cell disease.
Br J Haematol. 2023;200:633-642.
PubMed Abstract available

JOSEPH L, Corbasson A, Manceau S, Khimoud D, et al
Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease.
Br J Haematol. 2023;200:563-567.
PubMed Abstract available

TSITSIKAS DA, Rowe S, Bosch A, Hui C, et al
Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.
Br J Haematol. 2023;200:e50-e52.
PubMed

MCKEAGUE S, Peake N, Lovelock D, Chow J, et al
Acquired HbH disease diagnosed by HbA1c capillary electrophoresis.
Br J Haematol. 2023;200:687.
PubMed

KOEHL B, Claude L, Reminy K, Tarer V, et al
Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait.
Br J Haematol. 2023;200:812-820.
PubMed Abstract available

February 2023

POUTREL S, Boisson C, Nader E, Renoux C, et al
Clinical severity and blood rheology in patients with sickle cell anaemia and co-existing autoimmune disease.
Br J Haematol. 2023;200:e28-e31.
PubMed

AGUWA CJ, Cannon AD, Casella JF, Shapiro BK, et al
Current developmental screening practices in young children with sickle cell disease.
Br J Haematol. 2023;200:377-380.
PubMed Abstract available

HEITZER AM, Schreiber JE, Yuan X, Wang F, et al
Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controls.
Br J Haematol. 2023;200:358-366.
PubMed Abstract available

HU J, Gong S, Chen K, Yang R, et al
Haploidentical transplant for paediatric patients with severe thalassaemia using post-transplant cyclophosphamide and methotrexate: A prospectively registered multicentre trial from the Bone Marrow Failure Working Group of Hunan Province, China.
Br J Haematol. 2023;200:329-337.
PubMed Abstract available

SIRIWORADETKUN S, Thiengtavor C, Thubthed R, Paiboonsukwong K, et al
A comprehensive study of immune function and immunophenotyping of white blood cells from beta-thalassaemia/HbE patients on hydroxyurea supports the safety of the drug.
Br J Haematol. 2023;200:367-376.
PubMed Abstract available

RICCHI P
Liver fibrosis in young patients with transfusion-dependent thalassaemia (TDT), understanding the role of steatosis.
Br J Haematol. 2023;200:399-400.
PubMed Abstract available

PADENIYA P, Ediriweera D, De Silva AP, Niriella M, et al
The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients.
Br J Haematol. 2023;200:517-523.
PubMed Abstract available

January 2023

NGUYEN PC, Tiong IS, Westerman DA, Blombery P, et al
A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia.
Br J Haematol. 2023;200:e13-e16.
PubMed

ZHU D, Liang G, Zhang Y, Wei X, et al
Identification of haemolytic anaemia caused by glucose phosphate isomerase deficiency in a thalassaemia-endemic region: Correction of misdiagnosis and consideration of the cause of misdiagnosis.
Br J Haematol. 2023;200:e8-e12.
PubMed

MOISE KJ JR
Immunomodulation for early-onset haemolytic disease of the fetus/newborn: Can we delay the need for intrauterine transfusions?
Br J Haematol. 2023;200:11-12.
PubMed Abstract available

WILSON J
Rasburicase-induced methaemoglobinaemia and catastrophic oxidative haemolysis in undiagnosed G6PD deficiency.
Br J Haematol. 2023;200:7.
PubMed

VAN DIJK MJ, van Oirschot BA, Stam-Slob MC, Waanders E, et al
Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review.
Br J Haematol. 2023;200:249-255.
PubMed Abstract available

December 2022

ZAMAN BA, Rasool SO, Abdo JM
The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Br J Haematol. 2022 Dec 19. doi: 10.1111/bjh.18619.
PubMed Abstract available

LI M, Liu L, Ding B, Song X, et al
Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib.
Br J Haematol. 2022;199:e37-e42.
PubMed

WINER JC, Yee ME, Ataga KI, Lebensburger JD, et al
Patients with sickle cell disease who develop end-stage kidney disease continue to experience poor survival - A 19-year United States Renal Data System study.
Br J Haematol. 2022;199:e43-e47.
PubMed

DE LA IGLESIA INIGO S, Navarrete Bullon L, Stuckey R, Veiga Vaz A, et al
Cauda equina syndrome secondary to extramedullary erythropoiesis in a transfusion-dependent thalassemia patient following treatment with luspatercept: A case report.
Br J Haematol. 2022;199:e30-e33.
PubMed

RAJPUT RV, Ma X, Boswell KL, Gaudinski M, et al
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
Br J Haematol. 2022;199:679-687.
PubMed Abstract available

CONNELLY JA, Savani BN
Irradiation-free, T-cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits.
Br J Haematol. 2022;199:639-641.
PubMed Abstract available

VIAL Y, Lainey E, Leblanc T, Baudouin V, et al
De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.
Br J Haematol. 2022;199:739-743.
PubMed Abstract available

November 2022

AMPOMAH MA, Drake JA, Anum A, Amponsah B, et al
A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana.
Br J Haematol. 2022;199:411-426.
PubMed Abstract available

XU L, Lu Y, Hu S, Li C, et al
Unmanipulated haploidentical haematopoietic cell transplantation with radiation-free conditioning in Fanconi anaemia: A retrospective analysis from the Chinese Blood and Marrow Transplantation Registry Group.
Br J Haematol. 2022;199:401-410.
PubMed Abstract available

HAN J, Zhang X, Molokie RE, Njoku FU, et al
COVID-19 vaccination status and disease burden in patients with sickle cell disease.
Br J Haematol. 2022;199:e21-e24.
PubMed

OGUNSILE FJ, Stewart KJ, Kanter J, Lanzkron SM, et al
An evaluation of cardiopulmonary endurance and muscular strength in adults living with sickle cell disease.
Br J Haematol. 2022;199:597-602.
PubMed Abstract available

RODRIGUEZ CORTE J, Candal-Pedreira C, Ruano-Ravina A, Perez-Rios M, et al
Home-based blood transfusion therapy: A systematic review.
Br J Haematol. 2022;199:496-506.
PubMed Abstract available

October 2022

TORTI L
Life beyond alpha-thalassaemia: We are moving forward.
Br J Haematol. 2022;199:11-13.
PubMed Abstract available

PAALVAST Y, Moazzen S, Sweegers M, Hogema B, et al
A computational model for prediction of ferritin and haemoglobin levels in blood donors.
Br J Haematol. 2022;199:143-152.
PubMed Abstract available

CONRAN N, de Alvarenga Maximo C, Oliveira T, Fertrin KY, et al
Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study.
Br J Haematol. 2022;199:153-157.
PubMed

AKE-SITTIPAISARN S, Sirichotiyakul S, Srisupundit K, Luewan S, et al
Outcomes of pregnancies complicated by haemoglobin H-constant spring and deletional haemoglobin H disease: A retrospective cohort study.
Br J Haematol. 2022;199:122-129.
PubMed Abstract available

EYSSETTE-GUERREAU S, Khimoud D, Michaux K, Odievre MH, et al
Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination.
Br J Haematol. 2022;199:e8-e11.
PubMed

ESPERTI S, Boisson C, Robert M, Nader E, et al
Does G6PD deficiency cause further damage to red blood cells of patients with sickle cell anaemia?
Br J Haematol. 2022;199:289-291.
PubMed

QUARELLO P, Ramenghi U, Fagioli F
Diamond-Blackfan anaemia with iron overload: A serious issue.
Br J Haematol. 2022;199:171-172.
PubMed Abstract available

CHURCHILL D, Ali H, Moussa M, Donohue C, et al
Maternal iron deficiency anaemia in pregnancy: Lessons from a national audit.
Br J Haematol. 2022;199:277-284.
PubMed Abstract available

LECORNEC N, Castex MP, Reguerre Y, Moreau P, et al
Agranulocytosis in patients with Diamond-Blackfan anaemia (DBA) treated with deferiprone for post-transfusion iron overload: A retrospective study of the French DBA cohort.
Br J Haematol. 2022;199:285-288.
PubMed

September 2022

WULFTANGE WJ, Kucukal E, Man Y, An R, et al
Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow.
Br J Haematol. 2022;198:893-902.
PubMed Abstract available

CORNELISSEN HM, Musekwa EM, Glashoff RH, Esser M, et al
Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.
Br J Haematol. 2022;198:875-886.
PubMed Abstract available

ALIBERTI L, Gagliardi I, Gamberini MR, Ziggiotto A, et al
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria.
Br J Haematol. 2022;198:903-911.
PubMed Abstract available

ARITA K, Murakami J, Iwaki N, Hosono N, et al
An eltrombopag-induced remission of bone-marrow aplasia accompanied by marked leukoerythroblastosis and splenomegaly.
Br J Haematol. 2022;198:e75-e77.
PubMed

PATEL NG, Young D, Numan Y, Bhasin A, et al
The utility of peripheral blood film and haemolysis markers in evaluation of haemolytic anaemia at a tertiary care hospital.
Br J Haematol. 2022;198:927-929.
PubMed

VERCELLATI C, Zaninoni A, Marcello AP, Fermo E, et al
Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 years.
Br J Haematol. 2022;198:912-915.
PubMed Abstract available

TANTRAVAHI SK, Huber BD, Vagher J, Maese L, et al
Genome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.
Br J Haematol. 2022;198:e78-e81.
PubMed

SONGDEJ D, Kadegasem P, Tangbubpha N, Sasanakul W, et al
Whole-exome sequencing uncovered genetic diagnosis of severe inherited haemolytic anaemia: Correlation with clinical phenotypes.
Br J Haematol. 2022;198:1051-1064.
PubMed Abstract available

August 2022

WILSON J
Unlikely bedfellows - Sickle cells with malaria parasites.
Br J Haematol. 2022 Aug 12. doi: 10.1111/bjh.18412.
PubMed

MORICONI C, Dzieciatkowska M, Roy M, D'Alessandro A, et al
Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.
Br J Haematol. 2022;198:574-586.
PubMed Abstract available

ROY NBA, Da Costa L, Russo R, Bianchi P, et al
The use of next-generation sequencing in the diagnosis of rare inherited anaemias: A Joint BSH/EHA Good Practice Paper.
Br J Haematol. 2022;198:459-477.
PubMed

NISHIMURA JI, Usuki K, Ramos J, Ichikawa S, et al
Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
Br J Haematol. 2022;198:e46-e50.
PubMed

GAARTMAN AE, Strijdhorst A, van Es N, Tang MW, et al
Limited value of the D-dimer based YEARS algorithm to rule out pulmonary embolism in sickle cell disease and sickle cell trait.
Br J Haematol. 2022;198:e42-e45.
PubMed

GREEN NS, Van Doren L, Licursi M, Billings DD, et al
Anti-SARS-CoV-19 antibodies in children and adults with sickle cell disease: A single-site analysis in New York City.
Br J Haematol. 2022;198:680-683.
PubMed

SHARMA A, Leonard A, West K, Gossett JM, et al
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
Br J Haematol. 2022;198:740-744.
PubMed Abstract available

URSULE-DUFAIT C, Bengoufa D, Theodorou I, Villesuzanne C, et al
Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease.
Br J Haematol. 2022;198:e67-e70.
PubMed

OGBENNA AA, Akinsete AM, Kalejaiye OO, Matthew OK, et al
Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy.
Br J Haematol. 2022;198:745-752.
PubMed Abstract available

GELBENEGGER G, Jaeger U, Fillitz M, D'Sa S, et al
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open-label, extension trial.
Br J Haematol. 2022;198:e59-e62.
PubMed

July 2022

SCOTT C, Bartolovic K, Clark SA, Waithe D, et al
Functional impairment of erythropoiesis in Congenital Dyserythropoietic Anaemia type I arises at the progenitor level.
Br J Haematol. 2022;198:e10-e14.
PubMed

COOPER-SOOD JB, Hagar W, Marsh A, Hoppe C, et al
Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.
Br J Haematol. 2022;198:207-209.
PubMed

BUESCHE G, Teoman H, Schneider RK, Ribezzo F, et al
Evolution of severe (transfusion-dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage-associated failure of the eythropoietic niche.
Br J Haematol. 2022;198:114-130.
PubMed Abstract available

CAUGHEY MC, Derebail VK, Carden MA, Novelli EM, et al
Prevalence and outcomes of dehydration in adults with sickle cell trait: the Atherosclerosis Risk in Communities (ARIC) study.
Br J Haematol. 2022;198:397-400.
PubMed

GUO JJ, Cao L, Zhu HY, Miao Y, et al
T-cell large granular lymphocytic leukaemia with atypical immunophenotypes: A single-centre retrospective analysis of 17 cases.
Br J Haematol. 2022;198:e18-e22.
PubMed

KONGKIATKAMON S
Acute haemolysis following COVID-19 vaccination in a thalassaemic patient with G6PD deficiency.
Br J Haematol. 2022;198:221.
PubMed

EARLY ML, Linton E, Bosch A, Campbell T, et al
The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains.
Br J Haematol. 2022;198:382-390.
PubMed Abstract available

June 2022

DELAPORTA P, Terpos E, Solomou EE, Gumeni S, et al
Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia.
Br J Haematol. 2022;197:576-579.
PubMed Abstract available

PICCIN A, O'Connor-Byrne N, Daves M, Lynch K, et al
Autoimmune disease and sickle cell anaemia: 'Intersecting pathways and differential diagnosis'.
Br J Haematol. 2022;197:518-528.
PubMed Abstract available

HAN J, Molokie RE, Hussain F, Njoku F, et al
Voxelotor and albuminuria in adults with sickle cell anaemia.
Br J Haematol. 2022;197:e63-e64.
PubMed

SHEEHAN VA, van Beers EJ, Connes P, van Wijk R, et al
Comment on: Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
Br J Haematol. 2022;197:e61-e62.
PubMed

JOLY P, Boisson C, Renoux C, Caillat N, et al
Determinants of the point of sickling measured by oxygen gradient ektacytometry in sickle cell anaemia.
Br J Haematol. 2022;197:e56-e58.
PubMed

NARDO-MARINO A, Petersen J, Brewin JN, Birgens H, et al
Oxygen gradient ektacytometry does not predict pain in children with sickle cell anaemia.
Br J Haematol. 2022;197:609-617.
PubMed Abstract available

MARSHALL WH 5TH, Cleary EM, Della-Moretta S, Li R, et al
Elevated tricuspid regurgitation velocity is associated with increased adverse haematologic events during pregnancy in women with sickle cell disease.
Br J Haematol. 2022;197:795-801.
PubMed

May 2022

AMID A, Barrowman N, Odame I, Kirby-Allen M, et al
Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin-H fraction and "functional" haemoglobin level.
Br J Haematol. 2022;197:373-376.
PubMed Abstract available

LONGORIA JN, Heitzer AM, Hankins JS, Trpchevska A, et al
Neurocognitive risk in sickle cell disease: Utilizing neuropsychology services to manage cognitive symptoms and functional limitations.
Br J Haematol. 2022;197:260-270.
PubMed Abstract available

BAIN BJ, Littlewood T, Rees DC
What does the term 'sickle cell disease' mean?
Br J Haematol. 2022;197:381-382.
PubMed

ALTER BP, Giri N, McReynolds LJ, Altintas B, et al
Fanconi anaemia: A syndrome with distinct subgroups.
Br J Haematol. 2022;197:467-474.
PubMed Abstract available

VORA SM, Boyd S, Denny N, Jackson E, et al
Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotor.
Br J Haematol. 2022;197:502-504.
PubMed

April 2022

TANIGUCHI T, Nakayama S, Tanaka H, Rai S, et al
Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.
Br J Haematol. 2022 Apr 22. doi: 10.1111/bjh.18208.
PubMed Abstract available

SUN Y, Habara A, Le CQ, Nguyen N, et al
Pharmacologic induction of PGC-1alpha stimulates fetal haemoglobin gene expression.
Br J Haematol. 2022;197:97-109.
PubMed Abstract available

RIEU JB, Largeaud L, Da Costa L, Cougoul P, et al
Unexplained iron overload with haemolytic anaemia should prompt looking for morphological changes in erythroid precursors.
Br J Haematol. 2022;197:132.
PubMed

ROSS DM
Iron chelation for myelofibrosis-related anaemia during treatment with a Janus kinase inhibitor.
Br J Haematol. 2022;197:135-136.
PubMed

GARG M, Agarwal S, Altohami M
A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report.
Br J Haematol. 2022;197:e28-e31.
PubMed

BATISTA THC, Santana RM, Sobreira MJ, Arcanjo GS, et al
Up-regulation of miR-130a is related to leg ulcers in sickle cell anaemia.
Br J Haematol. 2022;197:e16-e18.
PubMed

TORRES LS, Teles LIM, Shaul ME, Fridlender ZG, et al
Accelerated low-density neutrophil transition in sickle cell anaemia may contribute to disease pathophysiology.
Br J Haematol. 2022;197:232-235.
PubMed

March 2022

MIODOWNIK H, Curtis SA, Olivia Ogu U, Bradford C, et al
Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease.
Br J Haematol. 2022;196:e41-e44.
PubMed

CECCHI N, Giannotta JA, Barcellini W, Fattizzo B, et al
A case of severe aplastic anaemia after SARS-CoV-2 vaccination.
Br J Haematol. 2022;196:1334-1336.
PubMed

CONSTANTINOU V, Papayanni PG, Mallouri D, Batsis I, et al
Case study of betibeglogene autotemcel gene therapy in an adult Greek patient with transfusion-dependent beta-thalassaemia of a severe genotype.
Br J Haematol. 2022;196:1401-1404.
PubMed

CHARNAY T, Cerino M, Gonnet K, Bonello-Palot N, et al
A novel SUPT5H variant associated with a beta-thalassaemia trait.
Br J Haematol. 2022;196:e70-e71.
PubMed

TAMURA S, Hori Y, Hiroi T, Morimoto M, et al
Pegcetacoplan for refractory paroxysmal nocturnal haemoglobinuria associated with the C5 genetic variant.
Br J Haematol. 2022;196:e57-e60.
PubMed

February 2022

RUND D
Laboratory diagnosis of iron deficiency: look out for the 'PITTs'.
Br J Haematol. 2022;196:464-465.
PubMed

XU LP, Yu Y, Cheng YF, Zhang YY, et al
Development and validation of a mortality predicting scoring system for severe aplastic anaemia patients receiving haploidentical allogeneic transplantation.
Br J Haematol. 2022;196:735-742.
PubMed Abstract available

FLETCHER A, Forbes A, Svenson N, Wayne Thomas D, et al
Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children.
Br J Haematol. 2022;196:523-529.
PubMed

POPLAWSKA M, Dutta D, Jayaram M, Salifu M, et al
Intestinal pathophysiological abnormalities in steady state and after vaso-occlusive crisis in murine sickle cell disease.
Br J Haematol. 2022;196:777-780.
PubMed Abstract available

GERRITSMA J, Bongaerts V, Eckhardt C, Heijboer H, et al
Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
Br J Haematol. 2022;196:769-776.
PubMed Abstract available

BARADE A, Aboobacker F, Korula A, Lakshmi K, et al
Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia.
Br J Haematol. 2022;196:724-734.
PubMed Abstract available

MAGGIO A
Cell erythroid maturation approach: a new paradigm in the road map towards a cure for beta-thalassaemia syndromes.
Br J Haematol. 2022;196:806-808.
PubMed

OAKLEY LL, Mitchell S, von Rege I, Hadebe R, et al
Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK.
Br J Haematol. 2022;196:1069-1075.
PubMed Abstract available

VLACHODIMITROPOULOU E, Garbowski M, Anne Solomon S, Abbasi N, et al
Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
Br J Haematol. 2022;196:1096-1104.
PubMed Abstract available

JONASSAINT CR, Lukombo I, Feldman R, Driscoll J, et al
Differences in the prevalence of mental health disorders among Black American adults with sickle cell disease compared to those with non-heritable medical conditions or no medical conditions.
Br J Haematol. 2022;196:1059-1068.
PubMed Abstract available

WHITE J, Callaghan MU, Gao X, Liu K, et al
Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.
Br J Haematol. 2022;196:1052-1058.
PubMed Abstract available

TANEJA K, Verma C, Mahajan A
Can ruxolitinib avert splenectomy in patients with thalassaemia: a short term case series.
Br J Haematol. 2022;196:1111-1113.
PubMed

VENUGOPAL J, Wang J, Guo C, Eitzman DT, et al
Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling.
Br J Haematol. 2022;196:1040-1051.
PubMed Abstract available

January 2022

NAVILLE AS, Lazaro E, Boutin J, Prot-Leurent C, et al
Acquired glucose 6-phosphate dehydrogenase (G6PD) deficiency in a patient with Chronic Myelomonocytic Leukemia.
Br J Haematol. 2022 Jan 6. doi: 10.1111/bjh.18037.
PubMed

BRODSKY RA, Lee JW, Nishimura JI, Szer J, et al
Lactate dehydrogenase versus haemoglobin: which one is the better marker in paroxysmal nocturnal haemoglobinuria?
Br J Haematol. 2022;196:264-265.
PubMed

RUND D
A Paradigm shift in genotype-phenotype relationships in beta-thalassaemia.
Br J Haematol. 2022;196:270-271.
PubMed

ROY NBA
Iron overload in inherited anaemias: why one size can't fit all.
Br J Haematol. 2022;196:266-267.
PubMed

SMITH WR, McClish DK, Lottenberg R, Sisler IY, et al
A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
Br J Haematol. 2022;196:193-203.
PubMed Abstract available

CHAPIN J, Cohen AR, Neufeld EJ, Vichinsky E, et al
An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
Br J Haematol. 2022;196:380-389.
PubMed Abstract available

MUSALLAM KM, Vitrano A, Meloni A, Addario Pollina S, et al
Primary HBB gene mutation severity and long-term outcomes in a global cohort of beta-thalassaemia.
Br J Haematol. 2022;196:414-423.
PubMed Abstract available

SHAH FT, Porter JB, Sadasivam N, Kaya B, et al
Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias.
Br J Haematol. 2022;196:336-350.
PubMed

CHEN N, Li Z, Huang Y, Xiao C, et al
Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnan
Br J Haematol. 2022;196:390-396.
PubMed Abstract available

KIENZLE SL, Rodeghier M, Liem RI
Heart rate variability associated with acute exercise challenge in children with sickle cell anaemia.
Br J Haematol. 2022;196:397-401.
PubMed Abstract available

ADEBAYO OC, Betukumesu DK, Nkoy AB, Adesoji OM, et al
Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia.
Br J Haematol. 2022;196:204-214.
PubMed Abstract available

GRIFFIN R, Panayiotou A, Allen P, Height S, et al
What is the role of chest X-ray imaging in the acute management of children with sickle cell disease?
Br J Haematol. 2022;196:402-413.
PubMed Abstract available

COLMAN KS, Pavord S, Roy N
A quality improvement project for the cost-effective management of maternal anaemia.
Br J Haematol. 2022;196:445-448.
PubMed

VASSEUR C, Domingues-Hamdi E, Pakdaman S, Galacteros F, et al
Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment.
Br J Haematol. 2022;196:183-192.
PubMed Abstract available

RISITANO AM, Peffault de Latour R
How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
Br J Haematol. 2022;196:288-303.
PubMed Abstract available

DEXTER D, McGann PT
Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease.
Br J Haematol. 2022;196:63-69.
PubMed Abstract available

MANABE M, Hagiwara Y, Asada R, Tanizawa N, et al
Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole-arm translocation, der(14;20)(q10;p10).
Br J Haematol. 2022;196:7.
PubMed

BARRITEAU CM, Chiu A, Rodeghier M, Liem RI, et al
Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia.
Br J Haematol. 2022;196:179-182.
PubMed Abstract available

HUGHES AD, Kurre P
The impact of clonal diversity and mosaicism on haematopoietic function in Fanconi anaemia.
Br J Haematol. 2022;196:274-287.
PubMed Abstract available

GABELLI M, Ademokun C, Cooper N, Amrolia PI, et al
Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post-transplant setting.
Br J Haematol. 2022;196:45-62.
PubMed Abstract available

December 2021

AOUN SA, Motabi I
Cold agglutinin disease after COVID-19 vaccine.
Br J Haematol. 2021;195:650.
PubMed

LIN J, Ye Y, Shang X, Zhang Y, et al
TEA domain transcription factor 4 modulates repression of fetal haemoglobin by direct binding to the gamma-globin gene promoters.
Br J Haematol. 2021;195:764-769.
PubMed Abstract available

NAKAGAWA N, Ishiyama K, Tanabe M, Yoroidaka T, et al
The effectiveness of immunosuppressive therapy in patients with aplastic anaemia secondary to chemoradiotherapy for cancers.
Br J Haematol. 2021;195:770-780.
PubMed Abstract available

BADAWY SM, Payne AB, Hulihan MM, Coates TD, et al
Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Cont
Br J Haematol. 2021;195:e160-e164.
PubMed

WILSON SR, Sears M, Williams E, Drapekin J, et al
Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.
Br J Haematol. 2021;195:e157-e160.
PubMed

November 2021

HALL R, Meenan J, Mihalca D, Katumba A, et al
The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey.
Br J Haematol. 2021;195:532-535.
PubMed

LILES DK, Shah NR, Scullin B, Gordeuk VR, et al
Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.
Br J Haematol. 2021;195:e150-e153.
PubMed

EL-AMIN N, Lauzon SD, Nietert PJ, Kanter J, et al
Which adults with sickle cell disease need an evaluation for pulmonary embolism?
Br J Haematol. 2021;195:447-455.
PubMed Abstract available

WANG W, Freeman M, Hamilton L, Carroll Y, et al
Developmental screening of three-year-old children with sickle cell disease compared to controls.
Br J Haematol. 2021;195:621-628.
PubMed Abstract available

BOISSON C, Renoux C, Nader E, Gauthier A, et al
Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without alpha-thalassaemia.
Br J Haematol. 2021;195:629-633.
PubMed Abstract available

LAFAURIE M, Maquet J, Baricault B, Ekstrand C, et al
Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Br J Haematol. 2021;195:456-465.
PubMed Abstract available

RANKINE-MULLINGS A, Reid M, Soares D, Taylor-Bryan C, et al
Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.
Br J Haematol. 2021;195:612-620.
PubMed Abstract available

BALLAS SK, Kuypers FA, Gordeuk VR, Hankins JS, et al
Time to rethink haemoglobin threshold guidelines in sickle cell disease.
Br J Haematol. 2021;195:518-522.
PubMed Abstract available

October 2021

HE Z, Sun X, Wang S, Bai D, et al
Ggct (gamma-glutamyl cyclotransferase) plays an important role in erythrocyte antioxidant defense and red blood cell survival.
Br J Haematol. 2021;195:267-275.
PubMed Abstract available

KARKOSKA K
Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease.
Br J Haematol. 2021;195:158-159.
PubMed

CAPPELLI B, Scigliuolo GM, Boukouaci W, Rafii H, et al
Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease.
Br J Haematol. 2021;195:e128-e131.
PubMed

HEITZER AM, Longoria J, Okhomina V, Wang WC, et al
Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood.
Br J Haematol. 2021;195:256-266.
PubMed Abstract available

DEREBAIL VK, Zhou Q, Ciccone EJ, Cai J, et al
Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.
Br J Haematol. 2021;195:123-132.
PubMed Abstract available

September 2021

MASLAH N, Ravdan O, Drevon L, Verger E, et al
Revisiting Diagnostic performances of serum erythropoietin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
Br J Haematol. 2021 Sep 25. doi: 10.1111/bjh.17848.
PubMed Abstract available

BARCELLINI W, Fattizzo B, Giannotta JA, Quattrocchi L, et al
COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey.
Br J Haematol. 2021;194:854-856.
PubMed

MUNARETTO V, Voi V, Palazzi G, Notarangelo LD, et al
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned.
Br J Haematol. 2021;194:851-854.
PubMed

HINES PC, Callaghan MU, Zaidi AU, Gao X, et al
Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
Br J Haematol. 2021;194:1074-1082.
PubMed Abstract available

OTENG-NTIM E, Pavord S, Howard R, Robinson S, et al
Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline.
Br J Haematol. 2021;194:980-995.
PubMed

STRATTON P
Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines.
Br J Haematol. 2021;194:950-953.
PubMed

GAARTMAN AE, Sayedi AK, Gerritsma JJ, de Back TR, et al
Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factors.
Br J Haematol. 2021;194:899-907.
PubMed Abstract available

PECKER LH, Sharma D, Nero A, Paidas MJ, et al
Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.
Br J Haematol. 2021;194:970-979.
PubMed Abstract available

RIEGER MJ, Stolz SM, Ludwig S, Benoit TM, et al
Daratumumab in rituximab-refractory autoimmune haemolytic anaemia.
Br J Haematol. 2021;194:931-934.
PubMed

BOUDHABHAY I, Boutin E, Bartolucci P, Bornes MI, et al
Impact of pre-eclampsia on renal outcome in sickle cell disease patients.
Br J Haematol. 2021;194:1053-1062.
PubMed Abstract available

MALINOWSKI AK, Kuo KHM, Tomlinson GA, Palcu P, et al
Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data.
Br J Haematol. 2021;194:1063-1073.
PubMed Abstract available

SARAF SL
The vasculopathic cord between pre-eclampsia and kidney function in sickle cell disease.
Br J Haematol. 2021;194:947-949.
PubMed

KUMKHAEK C, Uchida N, Tisdale JF, Rodgers GP, et al
Comparison of CD34(+) cells isolated from frozen cord blood and fresh adult peripheral blood of sickle cell disease patients in gene correction of the sickle mutation at late-stage erythroid differentiation.
Br J Haematol. 2021;194:e80-e84.
PubMed

GOTTGENS EL, Ligthart PC, Veldhuisen B, Veldthuis M, et al
Rh-null phenotype and stomatocytosis.
Br J Haematol. 2021;194:803.
PubMed

SCHEINBERG P
Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries.
Br J Haematol. 2021;194:954-969.
PubMed Abstract available

August 2021

NJOKU F, Zhang X, Shah BN, Machado RF, et al
Biomarkers of clinical severity in treated and untreated sickle cell disease: a comparison by genotypes of a single center cohort and African Americans in the NHANES study.
Br J Haematol. 2021;194:767-778.
PubMed Abstract available

ELSHERIF L, Scott LC, Wichlan D, Jones SK, et al
Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
Br J Haematol. 2021;194:e71-e73.
PubMed

QUINN CT, Niss O, Dong M, Pfeiffer A, et al
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia.
Br J Haematol. 2021;194:617-625.
PubMed Abstract available

TANGSRICHAROEN T, Natesirinilkul R, Phusua A, Fanhchaksai K, et al
Severe neonatal haemolytic anaemia caused by compound heterozygous KLF1 mutations: report of four families and literature review.
Br J Haematol. 2021;194:626-634.
PubMed Abstract available

July 2021

FATTIZZO B, Rizzo L, Giannotta JA, Mazzon F, et al
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
Br J Haematol. 2021 Jul 26. doi: 10.1111/bjh.17722.
PubMed

KILLICK SB, Ingram W, Culligan D, Enright H, et al
British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
Br J Haematol. 2021;194:267-281.
PubMed

MITTELMAN M, Oster HS
Thrombocytopenia in myelodysplastic syndromes: time to lift the embargo on thrombomimetics?
Br J Haematol. 2021;194:231-233.
PubMed

RASHKIN SR, Rampersaud E, Kang G, Ataga KI, et al
Generalization of a genetic risk score for time to first albuminuria in children with sickle cell anaemia: SCCRIP cohort study results.
Br J Haematol. 2021;194:469-473.
PubMed Abstract available

ESTEPP JH, Cong Z, Agodoa I, Kang G, et al
What drives transcranial Doppler velocity improvement in paediatric sickle cell anaemia: analysis from the Sickle Cell Clinical Research and Intervention Program (SCCRIP) longitudinal cohort study.
Br J Haematol. 2021;194:463-468.
PubMed Abstract available

ALNAFIE AN, Alateeq SA, Al-Muhanna FA, Alsulaiman AM, et al
Exome sequencing in high and low fetal haemoglobin Arab-Indian haplotype sickle cell disease.
Br J Haematol. 2021;194:e61-e64.
PubMed

PERES L, Monedero Alonso D, Nudel M, Figeac M, et al
Characterisation of Asp669Tyr Piezo1 cation channel activity in red blood cells: an unexpected phenotype.
Br J Haematol. 2021;194:e51-e55.
PubMed

VADOLAS J, Ng GZ, Kysenius K, Crouch PJ, et al
SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of beta-thalassaemia.
Br J Haematol. 2021;194:200-210.
PubMed Abstract available

TAHER AT, Viprakasit V, Cappellini MD, Kraus D, et al
Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent beta-thalassaemia.
Br J Haematol. 2021;194:474-477.
PubMed

WICKRAMASINGHE W, Dissanayake R, Raj R, Gooneratne L, et al
The first report of allogeneic haematopoietic stem cell transplantations for bone marrow failure performed in Sri Lanka.
Br J Haematol. 2021;194:e56-e58.
PubMed

TAMAGNE M, Pakdaman S, Bartolucci P, Habibi A, et al
Whole-blood CCR7 expression and chemoattraction in red blood cell alloimmunization.
Br J Haematol. 2021;194:477-481.
PubMed

RIEU JB, El Kassir A, Largeaud L, Dion J, et al
Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome.
Br J Haematol. 2021;194:8.
PubMed

WARE RE, Dertinger SD
Absence of hydroxyurea-induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia.
Br J Haematol. 2021;194:252-266.
PubMed Abstract available

PACE BS, Starlard-Davenport A, Kutlar A
Sickle cell disease: progress towards combination drug therapy.
Br J Haematol. 2021;194:240-251.
PubMed Abstract available

June 2021

PATON C, Mathews L, Groarke EM, Rios O, et al
COVID-19 infection in patients with severe aplastic anaemia.
Br J Haematol. 2021;193:902-905.
PubMed

HANDS K, Taylor C, Kotze A, Richards T, et al
Preoperative patient blood management during the SARS-CoV-2 pandemic.
Br J Haematol. 2021;193:1087-1092.
PubMed

STEINBERG MH
HbA2 induction: the merit of pancellularity in sickle cell disease.
Br J Haematol. 2021;193:1032-1033.
PubMed

HILLS RK
Diagnosing Diamond-Blackfan anaemia: 'Vorsprung durch Technik'.
Br J Haematol. 2021;193:1030-1031.
PubMed

BLAISE D, Savani BN
Alternative donor transplantation for severe aplastic anaemia in 2021: haplo donor, cord blood or both?
Br J Haematol. 2021;193:863-864.
PubMed

PORCU S, Simbula M, Marongiu MF, Perra A, et al
Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
Br J Haematol. 2021;193:1228-1237.
PubMed Abstract available

VAN DOOIJEWEERT B, Broeks MH, van Beers EJ, Verhoeven-Duif NM, et al
Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for Diamond Blackfan Anaemia.
Br J Haematol. 2021;193:1185-1193.
PubMed Abstract available

LIANG Y, Zhang X, Liu Y, Wang L, et al
GATA zinc finger domain-containing protein 2A (GATAD2A) deficiency reactivates fetal haemoglobin in patients with beta-thalassaemia through impaired formation of methyl-binding domain protein 2 (MBD2)-containing nucleosome remodelling and deacetylatio
Br J Haematol. 2021;193:1220-1227.
PubMed Abstract available

CHILDS RW, Tian X, Vo P, Purev E, et al
Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome.
Br J Haematol. 2021;193:951-960.
PubMed Abstract available

MAITLAND K, Kiguli S, Olupot-Olupot P, Opoka RO, et al
Transfusion management of severe anaemia in African children: a consensus algorithm.
Br J Haematol. 2021;193:1247-1259.
PubMed Abstract available

LAAS C, Lambert C, Senior McKenzie T, Sheldon E, et al
Improving the laboratory diagnosis of pyruvate kinase deficiency.
Br J Haematol. 2021;193:994-1000.
PubMed Abstract available

JANG T, Mo G, Stewart C, Egini O, et al
Antibiotic use in adults during sickle cell vaso-occlusive crisis: Is it time for a controlled trial?
Br J Haematol. 2021;193:1281-1283.
PubMed

MARTINO S, Arlet JB, Odievre MH, Jullien V, et al
Deficient mitophagy pathways in sickle cell disease.
Br J Haematol. 2021;193:988-993.
PubMed Abstract available

XU Y, Alfaro-Magallanes VM, Babitt JL
Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders.
Br J Haematol. 2021;193:882-893.
PubMed Abstract available

JUNG M, Mehta PA, Jiang CS, Rosti RO, et al
Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia.
Br J Haematol. 2021;193:971-975.
PubMed Abstract available

May 2021

UYOGA S, George EC, Bates I, Olupot-Olupot P, et al
Point-of-care haemoglobin testing in African hospitals: a neglected essential diagnostic test.
Br J Haematol. 2021 May 15. doi: 10.1111/bjh.17431.
PubMed Abstract available

BARCELLINI W, Colombatti R
The impact of Parvovirus B19 on hereditary haemolytic anaemias.
Br J Haematol. 2021;193:703-704.
PubMed

BOOTH GS, Savani BN, Langston AA
Pure red blood cell aplasia: patient management pitfalls in major ABO-incompatible haematopoietic cell transplantation.
Br J Haematol. 2021;193:701-702.
PubMed

ELBADRY MI, Khaled SAA, Ahmed NM, Abudeif A, et al
Acute human parvovirus B19 infection triggers immune-mediated transient bone marrow failure syndrome, extreme direct hyperbilirubinaemia and acute hepatitis in patients with hereditary haemolytic anaemias: multicentre prospective pathophysiological st
Br J Haematol. 2021;193:827-840.
PubMed Abstract available

LONGVAL T, Galimard JE, Lepretre AC, Suarez F, et al
Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
Br J Haematol. 2021;193:814-826.
PubMed Abstract available

VINCHI F, Sparla R, Passos ST, Sharma R, et al
Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.
Br J Haematol. 2021;193:637-658.
PubMed Abstract available

RUND D
Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?
Br J Haematol. 2021;193:466-480.
PubMed Abstract available

SARAF SL, Zhang X, Shah BN, Raslan R, et al
Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy.
Br J Haematol. 2021;193:628-632.
PubMed Abstract available

DENTON CC, Detterich JA, Coates TD, Wood JC, et al
Kidney iron deposition by R2* is associated with haemolysis and urinary iron.
Br J Haematol. 2021;193:633-636.
PubMed Abstract available

April 2021

BERNARD F, Uppungunduri CRS, Meyer S, Cummins M, et al
Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience.
Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17418.
PubMed Abstract available

CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
Br J Haematol. 2021;193:43-51.
PubMed

BENNETT R, Ruskova A
Atezolizumab-induced pure red cell aplasia.
Br J Haematol. 2021;193:10.
PubMed

LADU AI, Aiyenigba AO, Adekile A, Bates I, et al
The spectrum of splenic complications in patients with sickle cell disease in Africa: a systematic review.
Br J Haematol. 2021;193:26-42.
PubMed Abstract available

SHAFIEE S, Gelebart P, Popa M, Hellesoy M, et al
Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line.
Br J Haematol. 2021;193:415-419.
PubMed

CHENG Y, Shang X, Chen D, Pang D, et al
MicroRNA-2355-5p regulates gamma-globin expression in human erythroid cells by inhibiting KLF6.
Br J Haematol. 2021;193:401-405.
PubMed Abstract available

QUINTINO DE OLIVEIRA B, Catto LFB, Santana BAA, Tellechea MF, et al
Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
Br J Haematol. 2021;193:410-414.
PubMed Abstract available

March 2021

SAULSBERRY-ABATE AC, Partanen M, Porter JS, Podila PSB, et al
Cognitive performance as a predictor of healthcare transition in sickle cell disease.
Br J Haematol. 2021;192:1082-1091.
PubMed Abstract available

AL-SAMKARI H, Addonizio K, Glader B, Morton DH, et al
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
Br J Haematol. 2021;192:1092-1096.
PubMed Abstract available

EGOT M, Lasne D, Poirault-Chassac S, Mirault T, et al
Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Br J Haematol. 2021;192:909-921.
PubMed Abstract available

ATAGA KI, Staffa SJ, Brugnara C, Stocker JW, et al
Haemoglobin response to senicapoc in patients with sickle cell disease: a re-analysis of the Phase III trial.
Br J Haematol. 2021;192:e129-e132.
PubMed

OIKONOMOPOULOU C, Paisiou A, Komitopoulou A, Ioannidou ED, et al
Increased incidence of autoimmune cytopenias after allogeneic haematopoietic stem cell transplantation using a matched unrelated donor in children with beta-thalassaemia.
Br J Haematol. 2021;192:e127-e129.
PubMed

SACHDEV V, Tian X, Gu Y, Nichols J, et al
A phenotypic risk score for predicting mortality in sickle cell disease.
Br J Haematol. 2021;192:932-941.
PubMed Abstract available

RIBEIRO PR, Teixeira RDS, Souza AR, Pereira TCS, et al
Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations.
Br J Haematol. 2021;192:922-931.
PubMed Abstract available

February 2021

CAIRO MS, Savani BN
Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
Br J Haematol. 2021;192:678-680.
PubMed

OLSON TS
Paediatric severe aplastic anaemia treatment: where to start?
Br J Haematol. 2021;192:417-419.
PubMed

ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
Br J Haematol. 2021;192:761-768.
PubMed Abstract available

YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
Br J Haematol. 2021;192:769-777.
PubMed Abstract available

GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
Br J Haematol. 2021;192:605-614.
PubMed Abstract available

HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
Br J Haematol. 2021;192:e77-e81.
PubMed

DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
Br J Haematol. 2021;192:634-642.
PubMed Abstract available

VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
A complication risk score to evaluate clinical severity of thalassaemia syndromes.
Br J Haematol. 2021;192:626-633.
PubMed Abstract available

CASTLEMAN JS, Moise KJ Jr, Kilby MD
Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
Br J Haematol. 2021;192:425-432.
PubMed Abstract available

January 2021

KULASEKARARAJ AG, Marsh JCW
Romiplostim in aplastic anaemia - another tool in the armamentarium.
Br J Haematol. 2021;192:15-16.
PubMed

MINGOIA M, Caria CA, Ye L, Asunis I, et al
Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
Br J Haematol. 2021;192:395-404.
PubMed Abstract available

Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
Br J Haematol. 2021;192:e54-e57.
PubMed

SHARMA POUDYAL B, Gyawali B, Rondelli D
The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
Br J Haematol. 2021;192:e63-e65.
PubMed

GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
Br J Haematol. 2021;192:385-394.
PubMed Abstract available

PATEL A, Gan K, Li AA, Weiss J, et al
Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
Br J Haematol. 2021;192:158-170.
PubMed Abstract available

JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Br J Haematol. 2021;192:190-199.
PubMed Abstract available

CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
Liver complications of haemoglobin H disease in adults.
Br J Haematol. 2021;192:171-178.
PubMed Abstract available

MTENGA J, Orf K, Zheng J, Chamba C, et al
Haematopoietic stem cell transplantation in Tanzania.
Br J Haematol. 2021;192:17-21.
PubMed

SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
Br J Haematol. 2021;192:179-189.
PubMed Abstract available

MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
Br J Haematol. 2021;192:151-157.
PubMed Abstract available

December 2020

RUND D
The evolution of clinical research in thalassaemia: where has all the funding gone?
Br J Haematol. 2020;191:666-667.
PubMed

JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
Br J Haematol. 2020;191:897-905.
PubMed Abstract available

URIO F, Nkya S, Rooks H, Mgaya JA, et al
F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
Br J Haematol. 2020;191:888-896.
PubMed Abstract available

FORTE S, Eng B, Verhovsek M, Soulieres D, et al
Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
Br J Haematol. 2020;191:e129-e131.
PubMed

TANG D, Liu S, Sun H, Qin X, et al
All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
Br J Haematol. 2020;191:906-919.
PubMed Abstract available

PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
Br J Haematol. 2020;191:880-887.
PubMed Abstract available

VALI S, Mukhtar S, Nandi A, Wilson K, et al
Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
Br J Haematol. 2020;191:875-879.
PubMed Abstract available

November 2020

VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
PubMed Abstract available

WEI Z, Yang G, Huang Y, Peng P, et al
A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
Br J Haematol. 2020;191:e81-e83.
PubMed

PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
Br J Haematol. 2020;191:e97-e100.
PubMed

SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
Br J Haematol. 2020;191:e72-e76.
PubMed

HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
Br J Haematol. 2020;191:e70-e72.
PubMed

PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
Br J Haematol. 2020;191:476-485.
PubMed Abstract available

TOLE S, Dhir P, Pugi J, Drury LJ, et al
Genotype-phenotype correlation in children with hereditary spherocytosis.
Br J Haematol. 2020;191:486-496.
PubMed Abstract available

October 2020

HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.
PubMed

SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
Br J Haematol. 2020;191:e38-e40.
PubMed

PIKE A, Muus P, Munir T, Mitchell L, et al
COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
Br J Haematol. 2020;191:e1-e4.
PubMed

ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
Rheumatoid arthritis and sickle cell disease: A potential association.
Br J Haematol. 2020;191:e25-e28.
PubMed

BARGEHR C, Crazzolara R
Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
Br J Haematol. 2020;191:11.
PubMed

TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
Br J Haematol. 2020;191:263-268.
PubMed Abstract available

RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
Br J Haematol. 2020;191:107-114.
PubMed Abstract available

September 2020

NESR G, Koshy R, Foldes D, Kagdi H, et al
Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
Br J Haematol. 2020;190:e326-e328.
PubMed

OLATUNYA OS
Poverty and severity of childhood sickle cell disease.
Br J Haematol. 2020;190:819-821.
PubMed

WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
Br J Haematol. 2020;190:e349-e352.
PubMed

GERARD D, Bourin S, Phulpin A, Picard V, et al
Previously misdiagnosed red cell membrane disorder and familial consequences.
Br J Haematol. 2020;190:810.
PubMed

LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
Br J Haematol. 2020;190:809.
PubMed

MCGINNIS E, Smith TW
Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
Br J Haematol. 2020;190:641.
PubMed

DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
Br J Haematol. 2020;190:e295-e297.
PubMed

BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
Br J Haematol. 2020;190:939-944.
PubMed Abstract available

August 2020

APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
Br J Haematol. 2020;190:e221-e224.
PubMed

KULASEKARARAJ AG
Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
Br J Haematol. 2020;190:486-487.
PubMed

GIBSON JS
A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
Br J Haematol. 2020;190:488-489.
PubMed

COLOMBATTI R, Andemariam B
Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
Br J Haematol. 2020;190:309-310.
PubMed

MALINOWSKI AK
Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
Br J Haematol. 2020;190:306-308.
PubMed

MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
Br J Haematol. 2020;190:e250-e255.
PubMed

ANDREWS C, Maze D, Murphy T, Sibai H, et al
Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
Br J Haematol. 2020;190:467-470.
PubMed

FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
Br J Haematol. 2020;190:e157-e159.
PubMed

FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
Br J Haematol. 2020;190:e162-e166.
PubMed

LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
Br J Haematol. 2020;190:e233-e236.
PubMed

NOOMUNA P, Risinger M, Zhou S, Seu K, et al
Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
Br J Haematol. 2020;190:599-609.
PubMed Abstract available

TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
Br J Haematol. 2020;190:442-449.
PubMed Abstract available

ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
Br J Haematol. 2020;190:610-617.
PubMed Abstract available

SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
Br J Haematol. 2020;190:450-457.
PubMed Abstract available

WILSON S, Ellsworth P, Key NS
Pregnancy in sickle cell trait: what we do and don't know.
Br J Haematol. 2020;190:328-335.
PubMed Abstract available

July 2020

CHAKRAVORTY S, Rees D
Commentary on sickle cell non-invasive prenatal testing article.
Br J Haematol. 2020;190:20-21.
PubMed

JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
Br J Haematol. 2020;190:e45-e48.
PubMed

PEDROSA AM, Lemes RPG
Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
Br J Haematol. 2020;190:e39-e42.
PubMed Abstract available

NARDO-MARINO A, Brousse V, Rees D
Emerging therapies in sickle cell disease.
Br J Haematol. 2020;190:149-172.
PubMed Abstract available

KATTAMIS A
Diamond-Blackfan anaemia: understanding an old disease.
Br J Haematol. 2020;190:14-15.
PubMed

VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
Br J Haematol. 2020;190:119-124.
PubMed Abstract available

QUARELLO P, Garelli E, Carando A, Cillario R, et al
A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
Br J Haematol. 2020;190:93-104.
PubMed Abstract available

June 2020

LUZZATTO L
PNH phenotypes and their genesis.
Br J Haematol. 2020;189:802-805.
PubMed

HYACINTH HI, Idris IM
Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
Br J Haematol. 2020;189:1014-1015.
PubMed

GIRELLI D, Busti F
ERFE regulation in sickle cell disease: complex but promising.
Br J Haematol. 2020;189:1012-1013.
PubMed

KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
Br J Haematol. 2020;189:e240-e245.
PubMed

BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
Br J Haematol. 2020;189:e198-e200.
PubMed

PARTANEN M, Kang G, Wang WC, Krull K, et al
Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
Br J Haematol. 2020;189:1192-1203.
PubMed Abstract available

RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
Br J Haematol. 2020;189:954-966.
PubMed Abstract available

PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
Br J Haematol. 2020;189:800.
PubMed

MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
Br J Haematol. 2020;189:1204-1209.
PubMed Abstract available

AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
Br J Haematol. 2020;189:888-903.
PubMed Abstract available

PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
Distinctive and common features of moderate aplastic anaemia.
Br J Haematol. 2020;189:967-975.
PubMed Abstract available

May 2020

ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
Br J Haematol. 2020;189:e104-e108.
PubMed

SHAH BN, Hassan TO, Zhang X, McClain DA, et al
Increased iron stores influence glucose metabolism in sickle cell anaemia.
Br J Haematol. 2020;189:e184-e187.
PubMed

SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
Br J Haematol. 2020;189:e154-e157.
PubMed

GOUVEIA C, Duarte M, Norte S, Alves P, et al
Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
Br J Haematol. 2020;189:e147-e150.
PubMed

PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
Br J Haematol. 2020;189:566-572.
PubMed Abstract available

LEONARD A, Tisdale J, Abraham A
Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
Br J Haematol. 2020;189:408-423.
PubMed Abstract available

MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
Br J Haematol. 2020;189:559-565.
PubMed Abstract available

April 2020

ALI JS, Andrasik F, Berlin KS, Porter J, et al
Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
Br J Haematol. 2020;189:e27-e30.
PubMed

FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
Br J Haematol. 2020;189:e21-e23.
PubMed

ROPER D, Layton M, Rees D, Lambert C, et al
Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
Br J Haematol. 2020;189:24-38.
PubMed

THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
Br J Haematol. 2020;189:187-198.
PubMed Abstract available

FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
Br J Haematol. 2020;189:182-186.
PubMed Abstract available

NICKEL RS, Horan JT, Abraham A, Qayed M, et al
Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
Br J Haematol. 2020;189:162-170.
PubMed Abstract available

QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
Br J Haematol. 2020;189:e60-e63.
PubMed

March 2020

AUERBACH M, Georgieff MK
Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
Br J Haematol. 2020;188:814-816.
PubMed

AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
Br J Haematol. 2020;188:784-795.
PubMed Abstract available

HANSEN S, Wood DK, Higgins JM
5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
Br J Haematol. 2020;188:985-993.
PubMed Abstract available

CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
Br J Haematol. 2020;188:e80-e81.
PubMed

STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
Br J Haematol. 2020;188:976-984.
PubMed Abstract available

PAVORD S, Daru J, Prasannan N, Robinson S, et al
UK guidelines on the management of iron deficiency in pregnancy.
Br J Haematol. 2020;188:819-830.
PubMed

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.